Загрузка...
Understanding adverse events of immunotherapy: A mechanistic perspective
The treatment of many cancers has been revolutionized by immune checkpoint blockade (ICB) as a standard-of-care therapeutic. Despite many successes, a large proportion of patients treated with ICB agents experience immune-related adverse events (irAEs) in the form of clinical autoimmunity, ranging f...
Сохранить в:
| Опубликовано в: : | J Exp Med |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Rockefeller University Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754677/ https://ncbi.nlm.nih.gov/pubmed/33601411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20192179 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|